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BACKGROUND: Children and adolescents with type 1 diabetes (T1DM) can encounter a 
variety of factors that affect proper management of their diabetes, including mental health. Youth 
with diabetes have significantly higher rates of depression, anxiety, and mental health problems 
compared to the general population.  Anxiety is especially prevalent.  PURPOSE: The objective 
of this project was to evaluate anxiety screening of children and adolescents with T1DM during 
their routine diabetes visits.  Specifically, to assess for any trends in anxiety levels and patient 
characteristics including demographics, insulin regimen and A1C levels.  METHODS: A cross-
sectional, retrospective review of ambulatory electronic health records (AEHR) was conducted in 
the Pediatric Diabetes Clinic at the Barnstable Brown Diabetes Center (BBDC), University of 
Kentucky in Lexington, Kentucky.  Records from October 1, 2019 to September 20, 2020 were 
evaluated for utilization of the GAD-7 screening tool in children and adolescents with T1DM 
during routine follow-up diabetes care.  Patients from these records were on insulin therapy and 
had been seen for routine, follow-up diabetes care.  RESULTS: Overall, it was found that the 
majority of adolescents screened were anxious. Statistically significant findings in association 
with GAD-7 scores were found related to sex, years with a diabetes diagnosis and insulin 
regimen.  Females with T1DM were found to have higher GAD-7 scores compared to males with 
T1DM. Children and adolescents who have been diagnosed longer and those on insulin pump 
therapy were less anxious than those on multiple daily injection (MDI) therapy or shorter 
duration of T1DM. CONCLUSIONS: A majority of children and adolescents with T1DM 
screened for anxiety during routine follow-up of diabetes care were anxious. Findings support a 
need for increased awareness of anxiety in the T1DM adolescent population. A need for 
universal anxiety screening and interdisciplinary management is also supported.   
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Anxiety Screening in Children & Adolescents with Type 1 Diabetes Using the GAD-7 Tool 
Introduction 
Children and adolescents with type 1 diabetes (T1DM) can encounter a variety of factors 
that affect proper management of their diabetes, including mental health. Youth with diabetes 
have significantly higher rates of depression, anxiety, and mental health problems compared to 
the general population (Gallagher, 2017; Kanner, Hamrin & Grey, 2003). Anxiety is especially 
prevalent. In the United States, among children aged 3-17 years, 7.1% (approximately 4.4 
million) have been diagnosed with anxiety.  Among children and adolescents with T1DM, rates 
are estimated to be between 13-17% (Center for Disease Control and Prevention, “CDC”, 2020). 
These statistics reinforce the importance of understanding anxiety and the impact it has on 
children and adolescents with T1DM. The American Diabetes Association (ADA) recommends 
addressing all psychosocial and mental health issues early to prevent complications in diabetes 
management (“American Diabetes Association, “ADA”, 2018). Recommendations for children 
diagnosed with diabetes include screening anxiety at diagnosis and yearly as part of their routine, 
follow-up care. 
Background 
Mental health issues commonly described by adolescents with diabetes include fear of 
hypoglycemia and hyperglycemia, anxiety, disordered eating behaviors and depressive 
symptoms (ADA, 2018). Poor management of mental health issues are linked with worsening 
diabetes outcomes including non-adherence, poor glycemic control, reduced quality of life and 
higher rates of long-term diabetes complications (ADA, 2018).  Anxiety, including frequently 
worrying, in children and adolescents with T1DM can make diabetes self- management more 
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difficult.  Proper management of T1DM requires a complex and often demanding treatment 
regimen.  Daily requirements in self-management tasks can be overwhelming and stressful for 
the child or adolescent with T1DM and their family. Many children and adolescents with 
diabetes fear hypoglycemia in addition to common anxiety symptoms related to peer interactions 
and academic performance. Any level of increased anxiety can have a negative impact on 
diabetes control. Proper identification of mental health issues is extremely important.  
With proper anxiety screening and identification, resources can be made available to 
optimally manage any psychosocial complications. Children and adolescents struggling with 
anxiety need available resources and support to properly care and manage their health into 
adulthood. Children and adolescents with T1DM are set up for success when their mental health 
and diabetes are managed together.   
The Pediatric Diabetes Clinic at the University of Kentucky, Barnstable-Brown Diabetes 
Center (BBDC) see about 700 children with diabetes each year in any one of four clinics 
throughout the Commonwealth. Adolescents are a large portion of the population followed for 
management of diabetes.  Children and adolescents with T1DM, on insulin therapy, are routinely 
seen at three month intervals for evaluation of current diabetes care and management.  The 
Generalized Anxiety Disorder -7 (GAD-7) screening tool (Figure 1) is administered to children 
with diabetes, 11-21 years of age. This screening was implemented in 2019 and is provided at 
least annually as part of routine care and follow-up management of T1DM.  
Objective 
The objective of this project was to evaluate anxiety screening of children and 
adolescents with T1DM during their routine diabetes visits at University of Kentucky’s BBDC. 
Screening for psychosocial distress and mental health problems is a prime component of proper 
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diabetes management and care.  It is hoped that by assessing anxiety rates in this specific 
population, proper care will incur to not only better manage mental health but also diabetes 
control.  It is furthermore important to utilize a multidisciplinary team of specialists trained in 
pediatric diabetes management, but also knowledgeable of the additional challenges for youth 
with T1DM.  There is no current data on the rates of anxiety or severity of anxiety symptoms 
among children and adolescents with T1DM currently receiving care at UK's BBDC.   
Specific Aims 
At UK’s Division of Pediatric Endocrinology, the specific aims of this study were to evaluate the 
following:  
1. Trends in anxiety scores in children and adolescents with T1DM, aged 11 years to 21 
years. 
2. Demographic characteristics of children and adolescents with T1DM, aged 11 years - 
21 years who screened positive for anxiety. 
3. Duration of T1DM, age at diagnosis, years with T1DM, A1C levels, treatment 
regimen, and glucose monitoring activities of children and adolescents with T1DM, aged 
11 years - 21 years who screened positive for anxiety. 
This project is important to UK’s Division of Pediatric Endocrinology because of the increasing 
prevalence of mental health concerns in the adolescent population with T1DM. Recent research 
has highlighted trends with depression in this specific group, however anxiety is less understood. 
Assessing trends between anxiety and diabetes management will provide better opportunities for 
early intervention and interdisciplinary care to improve patient quality of life as it relates to 
diabetes management and psychological health.   
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The Iowa Model as the Theoretical Framework 
The Iowa Model is a framework designed to address the implementation of evidence-
based practice change to improve patient care and outcomes. The model helps to transition 
research findings into clinical practice in hopes of improving patient outcomes (Brown, 2014).  
The Iowa model allows providers to look at problem-focused or knowledge-focused triggers 
where evidence-based practice may help.  Screening for anxiety in youth with diabetes is a 
knowledge focused idea, as new research findings are showing the alarming trend of mental 
health concerns in adolescents with T1DM (ADA, 2018).  Most research has focused on 
depression rates in youth with T1DM, yet little has been explored regarding anxiety.  The Iowa 
model works step by step to identify if the issue at hand is priority for endocrine clinics and can 
help to implement a plan for screening anxiety in such clinics.  Therefore, by taking the steps of 
the Iowa Model, it was determined that an EBP project assessing GAD-7 scores was needed and 
important (Brown, 2014).    
Generalized Anxiety Disorder 7 – Item Scale (GAD-7) 
 The Generalized Anxiety Disorder Assessment (GAD-7) is a seven-item screening tool 
(Figure 1) that is used to measure and assess the severity of generalized anxiety disorder (GAD).  
Each item asks individuals to rate the severity of their symptoms over the past two weeks.  This 
tool has been utilized frequently in primary care patients, the general population and adolescents.  
Scoring allows providers to not only assess for presence of anxiety symptoms but also severity, 
differentiating from minimal, mild, moderate to severe.  
 This screening tool is available in various languages with free access to use online.  
Additionally, this is a self-administered tool and typically takes individuals one to two minutes to 
complete.  The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3 to the responses 
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“not at all”, “several days”, “more than half the days”, and “nearly every day”.  Scores are added 
together for the seven questions are and then assessed for severity.  Total scores from adding all 
seven answers range from 0-21.  To interpret scores, 0–4 is minimal anxiety;  5–9 is mild anxiety 
10–14 is moderate anxiety and 15–21 is severe anxiety. When used as a screening tool, further 
evaluation is recommended when the score is 10 or greater. 
 An additional portion of this screening tool is a final question asking individuals how 
difficult it is to do one’s work, take care of things at home, or get along with other people.    
Options include not difficult at all, somewhat difficult, very difficult or extremely difficult. This 
final portion serves as an adjunct to further assess for anxiety symptoms and severity. (Child 
Outcomes Research Consortium, 2021).   
Literature Review  
A keyword search was utilized on University of Kentucky’s (UK) online library. The 
university’s search function covers a large range of databases.  Example keywords include 
“diabetic adolescents”, “adolescents with Type I diabetes”, “diabetic youth”, “type I diabetes” 
and “youth with type I diabetes”.  Other keywords include “anxiety”, “mental health” and 
“psychiatric health”.  UK’s library search additionally provides suggested titles and keywords to 
improve the search process.  For example, “diabetic youth and anxiety” may have been searched 
while UK suggested a research article regarding adolescents with diabetes and mental health.   
 Articles were further narrowed down by selecting only English written articles.  
Additionally, articles were chosen that were published between 2005-2020, unless older articles 
resulted that are gold standard to this specific issue.  This search resulted in overall good quality 
articles including case studies, cross-sectional studies, systematic reviews, population-based 
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studies as well as general informative articles.  These study types are overall high to medium 
level evidence.    
Synthesis of Evidence  
There is an overwhelming amount of information supporting the link between higher 
anxiety rates in adolescents with T1DM (Table 1).  In conjunction with this, youth with both 
diabetes and anxiety also show a strong tendency of having higher hemoglobin A1C levels, bad 
glycemic control and poor quality of life (Adal et al., 2015; Almeida et al., 2018; Delamater, 
2009; Gonder-Frederick et al., 2006; Hood et al., 2006 & Stah-Pehe et al., 2015).  Strength of 
this evidence is relatively strong.  The only outlier with these results was one population-based 
cohort study (2014) that took place in Holland; they found no link between adolescent diabetes 
and increased rates of anxiety or any general mental health disorder (Silversten et al., 2014).   
Two articles reported parental roles and the influence of their mental health on their 
youths’ diabetes (Gonder-Frederick et al., 2006 & Herzer et al., 2009). Studies found that 
adolescents are affected by their parents’ and caregivers’ personality, especially those who have 
a tendency to be generally anxious (Delamater, 2009; Delamater et al., 1987 & Gonder-Frederick 
et al., 2006).   Primary recommendations from this literature review included the importance of 
routine screening for mental health disorders, specifically anxiety and depression, in primary 
care, but also diabetes clinics (Almedia et al., 2018; Delamater, 2009; Herzer et al., 2009, Hood 
et al., 2006 & Stahel-Pehe et al., 2014).  Strength of this evidence is relatively strong.    
Gaps in Literature 
Consistent results and relationships have also led to some consistent gaps in the literature.  
Many highlighted the importance of utilizing a multi-disciplinary approach when caring for these 
specific patients (Delamater, 2009; Delamater et al., 1987; Herzer et al, 2009 & Hood et al., 
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2006).  However, no research exists delving into the results from such care. Therefore, literature 
is needed on the positive effects of care that involves many providers, including mental health 
specialists, primary care providers, endocrinologists and further.   
Articles addressed parental involvement and influence on their adolescents’ diabetes care 
but also tendency to have anxiety and other mental health issues.  Further research is needed on 
parental involvement, specifically their negativity and personal anxiety levels related to degree 
of diabetes care (Gonder-Frederick et al., 2006).  More research is also needed focusing on care 
that involves parents’ and families’ role in their child’s overall care.  
The largest literature gap involves routine screening of anxiety in the endocrine setting.  
With common knowledge regarding this relationship between adolescent diabetes care and 
higher rates of anxiety, studies are needed that assess the importance of anxiety screening and 
outcomes when routine screening occurs.  With proper screening and early recognition, the 
relationship between anxiety in youth with T1DM and poor glycemic control can be better 
understood.   
Methods 
Design 
A cross-sectional, retrospective review of ambulatory electronic health records (AEHR) 
was conducted.  Records were reviewed for utilization of the GAD-7 screening tool and current 
anxiety screening practices for children and adolescents with T1DM.  Patients from these records 
were on insulin therapy and had been seen for routine, follow-up diabetes care between October 
1, 2019 to September 20, 2020 in the Pediatric Diabetes Clinic at the BBDC, University of 
Kentucky in Lexington, Kentucky.  Additionally, records were accessed from any of the three 
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established, regional travel clinics. Only records obtained during this time period were reviewed 
following IRB approval.  
This study involved data evaluation for quality improvement assessment purposes to 
determine additional needs for pediatric patients with T1DM and their support systems.  
Information gathered from AEHR included demographics, age at type I diabetes diagnosis, 
insulin therapy, glucose monitoring, A1C levels and co-existing conditions (Table 2).  GAD-7 
scores were also collected.  Additionally, whether or not endocrine clinic visits occurred during 
the COVID-19 pandemic were noted (Table 2).   
Setting 
Retrospective chart reviews were conducted at the Barnstable-Brown Diabetes Center 
(BBDC) at UK Healthcare in Lexington, Kentucky.  Initial establishment of pediatric diabetes 
care occurs in the pediatric diabetes clinic located at UK Healthcare’s Turfland center.  Routine 
follow-up diabetes care may occur in the pediatric diabetes clinic in Lexington, Kentucky or any 
of three regional travel clinics located throughout Appalachia in Kentucky (Monticello, 
Barbourville, or Pikeville).   
Sample 
The sample for this study included electronic health records of children and adolescents 
11 years to 21 years with T1DM followed at BBDC for diabetes care. This age range was 
selected due to the validated age range associated with the GAD-7 screening tool. All electronic 
health records of children and adolescents with T1DM seen for routine, follow-up diabetes care 
between October 1, 2019 and September 20, 2020 were eligible for enrollment. The inclusion 
criteria required for enrollment included the following: 1) 11 years -21 years of age, 2) T1DM 
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diagnosis and use of insulin therapy, 3) documentation of completed GAD-7 screening tool in 
AEHR, and 4) English as primary language.  
Exclusion criteria include the following: 1) Not on insulin therapy 2) Ages 0-10 years or 
greater than 21 years. 3) No evidence of completed GAD-7 screening tool available in AEHR, 4) 
Not capable of completing the GAD-7 for themselves due to impairment from other disabilities, 
5) emancipated minors, 6) those who are ward of the state, or 7) non-English as primary 
language. No exclusions based on gender, A1C level, or duration of diabetes were made. 
A total of 480 AEHR's were reviewed for inclusion into the study.  There were 81 
AEHR’s who met criteria.  
Data Collection 
Approval from the University of Kentucky Institutional Review Board (IRB) and the 
Healthcare System’s Office of Research and Administration was obtained prior to data 
collection.   Providers at Barnstable Brown Diabetes Center (BBDC) annually screen for anxiety 
in adolescent patients with T1DM using the GAD-7 scale. This is current provider practice. Once 
adolescents have completed the scale, it is reviewed by the provider, discussed with the family, 
and scanned into the child’s individual AEHR along with all other clinic visit documents. Office 
staff at BBDC assisted in enrolling eligible electronic health records into the study. Patient 
demographics, A1C levels, diabetes management regimen and GAD-7 scores were collected 
(Table 2).   The collected data was de-identified by a provider with password- protected access to 
AEHR prior to being made available to the primary investigator.  
Data available to the primary investigator did not include any of the 18 HIPAA personal 
identifiers information.  Specific study numbers were utilized by the provider collecting data in 
lieu of patient names to ensure de-identification of protected health information (PHI) and 
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maintain confidentiality.  Necessary documentation for the study were documented on a separate 
spreadsheet and all de-identified data was stored on a password protected computer (Figure 2).      
Data Analysis  
 Data was evaluated by statistical analysis.  The computer software program SPSS, 
version 25 was specifically used.  Descriptive statistics including means, standard deviation and 
frequency distributions described patient demographics.  Pearson’s correlation coefficient was 
utilized to assess any correlation between two continuous variables.  Selected variables that were 
assessed for correlation included age, years with a DM1 diagnosis, A1C levels and GAD-7 
scores.  A p level of 0.05 was used for statistical significance throughout.  The two sample t-test 
was used to assess any associations among nominal variables and the GAD-7 score. This 
included sex, insulin therapy, glucose monitoring and whether GAD-7 was taken during the 
COVID-19 pandemic.   
Results 
Demographics 
The average age of pediatric patients was 14.9 (SD=2.0; see Table 3).  Ages ranged from 
11 – 19 years old.  The majority (57%) were female, with 43% male.   Average age at DMI 
diagnosis was 8.62 (SD=2.03) with a range between 0-16 years.  Length of diabetes diagnosis 
averaged at 6.19 years (SD = 4.21) and ranged 0-17 years.   
Diabetes Regimen and A1C Levels  
  Multiple daily injection (MDI) was the more common insulin therapy (75.3%). Nearly 
25% were using pump therapy (24.7%).  Continuous glucose monitoring was used more 
frequently, at 51.9% compared to those who did not at 48.1%. The average A1C amongst 
adolescents was 9.08 (SD = 1.87) and ranged from 5.4 to the maximum read of 14%.  Forty-one 
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records (50.6%) reported no coexisting conditions.   A wide range of coexisting conditions were 
reviewed from the records, depression was highest at 14 (17.3%).  Other conditions included 
celiac disease (6.2%), ADHD (4.9%) and other (13.6%).  (Table 3).  
GAD-7 Results  
 The majority (44.4%) of adolescents were considered to have mild anxiety with a score 
of 5-9.  Almost 26%were considered moderately anxious, scoring between 10-12 on the GAD-7 
screening tool. There were 12 (14.8%) who had minimal to no anxiety symptoms with a score 
between 0-4.  Lastly, 14.8% scored severe anxiety with a range between 15-21. The majority 
(48.1%) of adolescents indicated they found it somewhat difficult to do work, take care of things 
and get along with others.  Over 28% (28.4%) found it ‘not difficult at all’, while 19.8% found it 
‘very difficult’.   A small amount (3.7%) found this to be ‘extremely difficult’.  (Table 3).  
COVID – 19 Pandemic  
 The majority (69.1%) of records screened during the study time frame did not occur 
during the COVID-19 pandemic. Thirty percent (30.9%) were screened during COVID-19.  
(Table 3).   
Discussion  
The purpose of this study was to evaluate anxiety screening of children and adolescents 
with DM1 during their routine diabetes visit at University of Kentucky’s BBDC.  Specifically, 
any trends in GAD-7 scores in adolescents with a type I diabetes diagnosis, ages 11 years to 21 
years old.  Additionally, to assess demographic characteristics in those who screened positive for 
anxiety.  Information specific to T1DM was also evaluated in this study, including age at 
diagnosis, years with T1DM, and treatment regimen including glucose monitoring activities.  Of 
the three objectives, statistical significance was found for gender, years with a diabetes 
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diagnosis, and treatment regimen in regard to anxiety scores.  Additionally, some key findings 
were found.  A major theme to note is the majority of these patients are anxious, only 14.8% of 
adolescent records were considered to have minimal to no anxiety. Eighty-five percent (85.2%) 
of the records scored mild to severe anxiety on the GAD-7 screening tool.   
Demographics  
The objective of examining age and GAD-7 scores showed to have no statistical 
significance (p 0.46, see Table 4).  This shows that no specific age has anxiety over others, but 
displays that as a whole, patients 11 years old to 21 years old have anxiety symptoms.  
Associations between sex and mean GAD-7 scores was statistically significant (p 0.04, see Table 
5), with females’ average GAD-7 score at 10.4, compared to males at 7.5.   This strongly 
suggests that females are more anxious than males.  Additionally, years of diabetes diagnosis 
was correlated with anxiety levels (p of 0.034), which is statistically significant.  This suggests 
that those who have had a type I diabetes diagnosis longer are less likely to be anxious, and vice 
versa with a new diagnosis.  
Diabetes Regimen, Glucose Monitoring and A1C Levels  
 A1C levels showed no correlation with GAD-7 anxiety scores (p 0.22, see Table 4).  This 
suggests that regardless of how well controlled one’s diabetes is, average adolescents have some 
level of anxiety.  Associations between therapy and GAD-7 scores was statistically significant (p 
0.009, see Table 5).  Adolescents who utilized pump therapy had average GAD-7 scores of 7.57, 
versus children who utilized MDI averaging at 9.91.  This association strongly suggests that 
adolescents who have insulin pumps are less likely to be anxious.  Continuous glucose 
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monitoring showed to have no statistical significance in regards to GAD-7 scores and anxiety 
levels.  Therefore, regardless if a child is able to continuously assess their glucose levels versus 
spot checking, average adolescents assessed had some level of anxiety.   
COVID-19 
 It was important to consider the potential that some adolescents may be experiencing 
compounding anxiety due to the many life changes brought on by the COVID-19 pandemic.  
However, taking the GAD-7 screening tool during the pandemic showed no statistical 
significance (p 0.211, see table 5).  The average score amongst records during COVID-19 was 
8.75 compared to 10.12 of records before COVID-19.   It is important to note that the majority 
(69.1%) of records screened during the study time frame did not occur during the COVID-19 
pandemic.    
Limitations 
 Several limitations were highlighted from this study.  Firstly, this is a small sample size 
and records were reviewed from a single site. This potentially limits generalizability.  Secondly, 
GAD-7 scores were not assessed in comparison records who do not have a diabetes diagnosis.  
Their scores would be a good correlation to assessing levels in solely adolescents with DMI.   
Thirdly, it is hard to assess for and evaluate confounding factors.  Adolescents may have 
many reasons as to why they are feeling anxious.  It may not only be related to their type I 
diabetes diagnosis, but may be a result of their family environment, current school assignments 
and stressors, genetics and further.  The level of support from family and support systems can 
further affect these children, as studies have shown that caregivers who are stressed about 
managing diabetes affect their children as well (Delamater, 2009; Delamater et al., 1987 & 
Gonder-Frederick et al., 2006).  
 20 
 Additionally, COVID-19 is a large source of stress and change.  There was no statistical 
difference between records screened before and after the pandemic. However, only 25 of the 81 
records took place during COVID-19. This is large limitation, as many are likely feeling 
compounding stress during this time, however the small number of records made this association 
hard to assess.  Another limitation includes the GAD-7 screening tool itself; many adolescents 
may not feel comfortable being truthful on such surveys.  It is possible that symptoms were not 
accurately accounted for as some youth may not want to discuss their mental health.   
Implications for Future Practice  
 This study identifies recommendations for future research as well as care changes in 
endocrine clinics.  Highlighting upon the limitations, it would be important to not only assess 
adolescents with T1DM, but also assess GAD-7 scores in children without a confounding 
diagnosis.  The scores would allow one to juxtaposition and further assess what the high anxiety 
scores suggest.  Additionally, it would be helpful to further assess anxiety by also administering 
the Fear of Hypoglycemia Survey (FOH).  This survey assesses how blood glucose levels affect 
how adolescents behave as well as assesses their degree of worrying.  With so many adolescents 
in this study (85.2%) scoring mild to severe anxiety on the GAD-7, it would be very helpful to 
assess if their worry stems mostly from their diagnosis or is a result of many factors.   
 As mentioned, it might further be helpful to assess parental roles, perceptions and 
influences regarding their child’s diagnosis and compounding anxiety. The Screen for Child 
Anxiety Related Disorders assessment (SCARED) evaluates parental awareness of their child’s 
anxiety symptoms.  Not only assessing parental thoughts on anxiety, but also how the adolescent 
manages and handles their T1DM is important too.  With proper support, it is hoped that children 
would feel less anxious.   
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   With the knowledge gained from this project, an assessment of next steps in the 
endocrine setting is also needed.  A large goal to work towards is multidisciplinary care with not 
only endocrine providers but also mental health specialists.  Adolescent patients are set up for 
success when mental health and diabetes are managed together, as youth feel empowered to 
recognize their feelings and ask for help.  Therefore, recommendations for future research would 
not only involve further assessment of anxiety in the adolescent population, but also involved 
other disciplines to best manage young patients.  As mental health is incorporated, it is hoped 
that these young patients will feel more supported and able to best manage their diabetes.   
Conclusion  
 This study hopes to increase awareness of anxiety in the adolescent population with 
T1DM.  The main purpose was to assess trends between characteristics of adolescent patients 
with a T1DM diagnosis and their GAD-7 scores. Females were found to be more anxious than 
males while youth who have been diagnosed longer than others showed less anxiety. 
Additionally, adolescents who utilized an insulin pump were on average less anxious than youth 
who used MDI.  Some expected correlations were not found to be statistically significant.  
However, the large key theme acknowledged from this study was that the vast majority of 
adolescent patients with T1DM are anxious.  Therefore, goals from this project suggest the need 
of further anxiety screening and interdisciplinary management.   With mental health properly 
managed as well, it is believed that there will be an improvement in diabetes care by adolescents 
with T1DM.  Most importantly, with better coping mechanisms and diabetes management, there 
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Table 1. Synthesis Table to summarize findings 
 
Study 





DMI and HA or DMI/HA 





Adal et al.  2015 14.7 CS   R1, R2 SL 
Almeida et 
al. 2018 14 CCS R1 














et al.  2013 17.1 CS R1, R2 SL 
Delamater, 
A.M.  2009 NA 
N/A -- 




for screening  
Delamater 
et al. 1987 15.4 CCS 
R1, R2, additionally 
assessed difference in 
coping mechanisms 
















R1, R2, additionally 
parental influence / 
perception 






et al.  2013 
Between 
13-18 RCT 
Nothing Ventured Nothing 
Gained online tool 
Positive 
intervention 
for DMI QOL 
Herzer et 




CCS R1, R2 NSL in R1, SL in R2 
Hood et al. 2006 14.9 CS R2 SL 
Silversten 
et al.  2014 19.9 PBC R1 NSL 
Stah-Pehe 
et al.   2014 
Between 
11-13 PBC R1, R2 
SL as well as 
SL with QOL 
 
ABBREVIATION KEY: CCS = case control study; CS = cross-sectional; DMI = Type I 
Diabetes diagnosis; HA= history of / or diagnosis of anxiety; NA = not applicable; NSL = no 
significant relationship link; PBC = population based cohort; R1 = Relationship of DMI and 
anxiety; R2 = Relationship of DMI and anxiety with poor glycemic control; RCT = Randomized 


























Table 2.  Data gathered from AEHR  
 




Gender Male, Female Nominal Medical Records 
Age Age in years Interval/Ratio Medical Records 
Type I Diabetes Information 
Age at diagnosis   Age in years when diagnosed with Type I 
diabetes   
Interval/Ratio Medical Records 
Years with DM1 Length of current Type I diabetes diagnosis  Interval/Ratio Medical Records 
Type of therapy Insulin pump or multiple dose insulin Nominal Medical Records 
Continuous Glucose 
monitoring 
Yes or no  Binary  Medical Records 
Hemoglobin A1C 
Levels  
A1C = average blood glucose levels for past 2-
3 months, as a percentage  
Interval/Ratio Medical Records 




The GAD-7 score is calculated by assigning 
scores of 0, 1, 2, and 3 to the responses “not at 
all”, “several days”, “more than half the days”, 
and “nearly every day”.  Scores are added 
together for the seven questions are and then 
assessed for severity.  Total scores from adding 
all seven answers range from 0-21.  To 
interpret scores, 0–4 is minimal anxiety; 5–9 is 
mild anxiety 10–14 is moderate anxiety and 
15–21 is severe anxiety. When used as a 
screening tool, further evaluation is 
recommended when the score is 10 or greater. 
Ordinal  Medical Records 
COVID-19 Pandemic     
Was routine endocrine 
visit during the 
pandemic? 















Table 3. Descriptive summary of record characteristics (N = 81) 
 
 Mean (SD); range or n (%) 
Age, years 14.9 (2.0); 11-19 
Sex 
   Male 




Age at diagnosis 8.62 (2.03); 0-16 
Year with diabetes 6.19 (4.21); 0-17 
Therapy  
   Multiple Dose Insulin (MDI) 




Continuous Glucose Monitoring (CGM) 
   Yes 




A1C 9.08 (1.87); 5.4-14.0 
Coexisting Conditions 
  ADHD 
  Asthma 
  Celiac disease  
  Depression  
  Growth Hormone Deficiency  
  Hyperthyroidism  
  Hypothyroidism  
  None 
  Other  
  Post-traumatic stress disorder  














   1. Feeling nervous, anxious or on edge  
   2. Not being able to stop or control   
       worrying 
   3. Worrying too much about different things  
   4. Trouble relaxing  
   5. Being so restless that it is hard to sit still  
   6. Becoming easily annoyed or irritable  
   7. Feeling afraid, as if something awful  












   Minimal 
   Mild 
   Moderate 




21 (25.9%)  
12 (14.8%) 
Difficulty with doing your work, take care of 




   Not difficult at all 
   Somewhat difficult 
   Very difficult 





Patient seen during Covid-19 pandemic  
   Yes 





Table 4. Correlations among continuous variables and GAD score 
 Correlation coefficient r (p) 
Age -0.08 (.46) 
Years with diabetes -0.24 (.034) 
A1C 0.22 (.053) 
 
 
Table 5. Associations among nominal variables and GAD -7 score 




   Female 






   Multiple Dose Insulin  







   Yes 






Patient seen during Covid-19 
pandemic  
   Yes 
















Figure 1. GAD-7 Screening Tool 
 
 







Figure 2.  Study Data Collection form  
 
 
Case # _____________ 
 
Age ________  Gender ________ 
 
Age at Dx _______   Years with T1DM _______ 
Therapy:  Pump _______  MDI _____ CGM use ______ 
Co-existing conditions/meds ________ 
 












Difficulty with doing your work, take care of things, get along with others: 
Not at all   ___ 
Somewhat difficult  ___ 
Very difficult  ___ 
     Extremely difficult  ___ 
 
 
 
 
 
 
